Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer

17 Feb 2022

Abstract excerpt

The standard treatment for small cell lung cancer (SCLC) has not changed in decades. Recently, important advances have been made in immunotherapy. However, analysis of these trials suggests that only a small proportion of patients benefit from immune checkpoint blockade (ICB). Identifying these patients is a clinical challenge. In this study, we applied the ESTIMATE calculation to calculate immune scores in 159...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35252266
DOI: 10.3389/fmed.2022.834725

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung CancerPMID 35252266Read ↗

Costimulatory Molecule Expression Profile as a Biomarker to Predict Prognosis and Chemotherapy Response for Patients With Small-cell Lung CancerSemantic proximity Read ↗

Construction of an immunogenic cell death related gene signature: A new prognostic model for small cell lung cancerSemantic proximity Read ↗

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung CancerSemantic proximity Read ↗

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.Semantic proximity Read ↗

Expression and potential role of CCL4 in CD8+T cells in NSCLC.Semantic proximity Read ↗

Exploring effective biomarkers and potential immune related gene in small cell lung cancerSemantic proximity Read ↗

STAT3/ miR-486 /CCL20 regulates the migration and invasion of human lung adenocarcinoma cellsSemantic proximity Read ↗

CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysisSemantic proximity Read ↗

Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessmentSemantic proximity Read ↗

LAG-3 and PD-1/PD-L1 inhibitors might become a promising treatment for small cell lung cancerSemantic proximity Read ↗

Inflammation Scores as Prognostic Biomarkers in Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

LAG-3 and PD-1/PD-L1 Inhibitors Might Become a Promising Treatment for Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.